Gastrointestinal Stromal Tumors
Showing NaN - NaN of 10
Gastrointestinal Stromal Tumors Trial in Houston (Regorafenib)
Not yet recruiting
- Gastrointestinal Stromal Tumors
-
Houston, TexasM D Anderson Cancer Center
Oct 12, 2023
Gastrointestinal Stromal Tumors Trial in Worldwide (DCC-2618, Placebo Oral Tablet)
Completed
- Gastrointestinal Stromal Tumors
- DCC-2618
- Placebo Oral Tablet
-
Scottsdale, Arizona
- +34 more
Nov 17, 2022
Gastrointestinal Stromal Tumors, Advanced Systemic Mastocytosis, Advanced Cancers Trial in Worldwide (DCC-2618)
Active, not recruiting
- Gastrointestinal Stromal Tumors
- +2 more
-
Scottsdale, Arizona
- +25 more
Apr 16, 2021
Symptom Inventory for Gastrointestinal Stromal Tumors
Unknown status
- Gastrointestinal Stromal Tumors
- Questionnaires
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 9, 2020
Gastrointestinal Stromal Tumors Trial in United States (Imatinib mesylate)
Terminated
- Gastrointestinal Stromal Tumors
- Imatinib mesylate
-
Los Angeles, California
- +12 more
Aug 22, 2013
Gastrointestinal Stromal Tumors (GIST) Registry
Completed
- Gastrointestinal Stromal Tumors
- GIST Registry
-
Houston, TexasUT MD Anderson Cancer Center
Aug 1, 2012
Gastrointestinal Stromal Tumors Trial in Worldwide (Nilotinib, Best Supportive Care (BSC) +/- imatinib or sunitinib)
Completed
- Gastrointestinal Stromal Tumors
- Nilotinib
- Best Supportive Care (BSC) +/- imatinib or sunitinib
-
Los Angeles, California
- +34 more
Jun 5, 2012
Gastrointestinal Stromal Tumors Trial in Houston (Imatinib Mesylate (Gleevec))
Completed
- Gastrointestinal Stromal Tumors
- Imatinib Mesylate (Gleevec)
-
Houston, TexasUT MD Anderson Cancer Center
Aug 4, 2011